EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Two Dimensional QSAR of Novel Pyrazole-Benzimidazole Derivatives for Anti-Tumor Activity Against Hct116 Cell Line

Arun Kumar Rai, Abhishek Yadav, Shivraj Pandey, Manoj Rathore, Malviya Kapil, Raghuwanshi Ramsaneh

World Journal of Current Medical and Pharmaceutical Research · 10.05.2026 · 1-7

DOI: 10.37022/wjcmpr.v8i2.391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Current Medical and Pharmaceutical Research, online erschienen am 10.05.2026. Verfasst von Arun Kumar Rai und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to develop and validate two-dimensional Quantitative Structure–Activity Relationship (2D-QSAR) models for novel pyrazole-benzimidazole derivatives to predict their anti-tumor activity against the HCT116 cancer cell line. A dataset of 37 derivatives reported in previous studies was selected, and IC50 values were converted into pIC50 for correlation analysis. Molecular structures were drawn using ChemDraw, energy-minimized with Chem3D MM2, and further optimized using MOPAC. Physicochemical descriptors, including molar refractivity, molecular mass, partition coefficient (LogP), LogS, and polar surface area, were calculated. Statistical analysis and model generation were performed using VALSTAT through multiple linear regression (MLR) with stepwise variable selection. Several QSAR models were generated, among which Model 1 showed the best statistical performance with r² = 0.1078 and standard deviation = 0.1464. The study revealed that molar refractivity, lipophilicity, and polar surface area significantly influenced cytotoxic activity. Increased molar refractivity and lipophilicity were associated with enhanced anti-tumor activity, indicating that bulky and less polar substituents favored enzyme inhibition. In contrast, higher polar surface area negatively affected activity. Validation using cross-validation and external test set prediction confirmed the predictive reliability of the developed models, with predicted pIC50 values closely matching experimental observations except for a few outliers. Overall, the findings demonstrate that steric and electronic properties play a crucial role in determining the anti-tumor potential of pyrazole-benzimidazole derivatives and may assist in designing improved chemotherapeutic candidates.

Zitieren

APA

Rai, A. K., Yadav, A., Pandey, S., Rathore, M., Kapil, M., & Ramsaneh, R. (2026). Two Dimensional QSAR of Novel Pyrazole-Benzimidazole Derivatives for Anti-Tumor Activity Against Hct116 Cell Line. World Journal of Current Medical and Pharmaceutical Research, 1-7. https://doi.org/10.37022/wjcmpr.v8i2.391

Vancouver

Rai AK, Yadav A, Pandey S, Rathore M, Kapil M, Ramsaneh R. Two Dimensional QSAR of Novel Pyrazole-Benzimidazole Derivatives for Anti-Tumor Activity Against Hct116 Cell Line. World Journal of Current Medical and Pharmaceutical Research. 2026:1-7. doi:10.37022/wjcmpr.v8i2.391

BibTeX
@article{Rai2026,
  author = {Rai, Arun Kumar and Yadav, Abhishek and Pandey, Shivraj and Rathore, Manoj and Kapil, Malviya and Ramsaneh, Raghuwanshi},
  title = {Two Dimensional QSAR of Novel Pyrazole-Benzimidazole Derivatives for Anti-Tumor Activity Against Hct116 Cell Line},
  journal = {World Journal of Current Medical and Pharmaceutical Research},
  year = {2026},
  pages = {1--7},
  doi = {10.37022/wjcmpr.v8i2.391}
}
Kostenlos starten →